General descriptionLangerin is a type II transmembrane C-type lectin associated with the formation of Birbeck granules in Langerhans cells. The demonstration of langerin immunoreactivity is considered an adjunct or alternative to CD1a antigen expression as evidence to aid in the diagnosis of Langerhans cell histiocytosis. Evaluation of langerin expression is valuable in circumstances where a diagnosis of Langerhans cell histiocytosis is suspected, but cannot be confirmed due to lack of CD1a immunoreactivity. A panel of antibodies against CD1a, langerin, CD21, CD23, CD35 and S100 is very useful in the distinction of Langerhans cell histiocytosis, histiocytic sarcoma, interdigitating dendritic cell sarcoma, follicular dendritic cell sarcoma, disseminated juvenile xanthogranuloma, and Rosai-Dorfman disease (sinus histiocytosis with massive lymphadenopathy).
Physical formSolution in Tris Buffer, pH 7.3-7.7, with 1% BSA and <0.1% Sodium Azide
Preparation NoteDownload the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.
Analysis NoteOther NotesFor Technical Service please contact: 800-665-7284 or email:
[email protected]Langerin Positive Control Slides, Product No.
392S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).
Legal InformationCell Marque is a registered trademark of Merck KGaA, Darmstadt, Germany
